Navigation Links
Next Inning Technology Research Identifies Winning Option Writing Strategies on Undervalued Stocks
Date:3/11/2009

PRINCETON, N.J., March 11 /PRNewswire/ -- Next Inning Technology Research (http://www.nextinning.com), a subscription service focused on semiconductor and technology stocks, announced it has published a series of reports updating outlooks for Analog Devices (NYSE: ADI), Maxim Integrated Products (Nasdaq: MXIM), Pfizer (NYSE: PFE), DNP Select Income Fund (NYSE: DNP), and more.

Throughout this challenging period in the market, Editor Paul McWilliams has helped his subscribers identify uniquely positioned tech sector opportunities. These include a specialty semiconductor stock that has returned 64% since McWilliams added it to the Next Inning model portfolio late last year.

By taking a free test drive of Next Inning, you'll receive real-time notification of Next Inning model portfolio buy and sell orders, the seven Next Inning Paradigm Papers covering key, long-term tech trends, and the exclusive "2009 Guide to Undervalued Tech Stocks." These reports cover nearly 100 technology companies and are chock full of charts and ratings that identify potential big winners for 2009 and which stocks investors should avoid. To accept this offer, visit the following link:

https://www.nextinning.com/subscribe/index.php?refer=prn790

The Black-Scholes model doesn't take into account intrinsic value when valuing options, only volatility and time. In a high volatility environment, there is often an opportunity to "harvest" a premium by writing options in high quality stable companies with limited downside risk to intrinsic value. Next Inning has applied this approach to the technology sector in the past with success, has recently identified several new ideas, and will publish a several more taking advantage of these anomalies.

McWilliams also looks at these topics:

-- Why does McWilliams think the price of DNP is artificially depressed? Does he think the 12%+ dividend is safe?

-- How can investors lock in returns greater than 20% with Pfizer and, at the same time, drop their risk exposure below what it would be if they just held the stock?

-- What strategy can investors use to lock in a 28% return with a very low risk exposure in the Tech sector?

-- Why does McWilliams think Analog Devices is destined to beat its guidance this quarter? How can investors lock in a 41% total return with Analog Devices, yet expose themselves to less risk than a typical Analog Devices shareholder?

Founded in September 2002, Next Inning's model portfolio has returned 118% since its inception versus 5% for the Nasdaq.

About Next Inning:

Next Inning is a subscription financial newsletter focused on technology stocks. Editor Paul McWilliams is a 20+-year semiconductor industry veteran.

NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit adviserinfo.sec.gov for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

CONTACT: Marcia Martin Next Inning Technology Research, +1-888-278-5515


'/>"/>
SOURCE Indie Research Advisors, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Olympic Gold Winning Supplement Lands in the US
2. Award Winning Photographer and Museum Founder to Donate Iconic Images In Support of the Innocence Project
3. Inspired Cancer Survivor Launches Customized Hair Replacement Techniques at Award-Winning Hair Salon
4. MidMichigan Health Cuts Out Trans Fats Beginning March 1
5. Disability Community Humble Beginnings Lead to Great Things at Disabled World
6. Governor Crist Proclaims Tobacco Free Florida Week Beginning February 27
7. Icagen Board Beginning to Follow Xmark Direction
8. A Newly Approved CMS Medicare Package Expands Reimbursement Coverage for Telehealth Originating Sites Beginning January 1, 2009
9. Pennsylvania to Offer Free Nicotine Replacement Therapy Kits Beginning Feb. 2
10. Author Shares Nine Resolutions for 2009 to Create a Winning Corporate Culture
11. Cadient Group Expands Award-Winning Capabilities with Key New Hires
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... ... Blood Pressure products . , High blood pressure affects millions of people ... high blood pressure can lead to heart disease, stroke, kidney disease, and hardening ...
(Date:5/26/2016)... , ... May 26, 2016 , ... HealthPostures, ergonomics designer ... chair , furniture that may support women during pregnancy. Potential benefits of using the ... improved rest and comfort and healthier levels of sitting and standing. , Need for ...
(Date:5/26/2016)... ... May 26, 2016 , ... Bunion Bootie is a great option ... and save. For a limited time only (offer expires May 31, 2016) customers can ... one, by using the promo code "Memorial" at checkout. The more Bunion Booties purchased, ...
(Date:5/25/2016)... (PRWEB) , ... May 26, 2016 , ... The 12th ... 6pm to 7.30pm PST at HP in Palo Alto, CA. This Bay Area biotech ... be led by clinical trial experts from the pharmaceutical company Hallux, biopharma Apexigen, Contract ...
(Date:5/25/2016)... Chicago, IL (PRWEB) , ... May 25, 2016 ... ... HealthScape Advisors,” said Steven Young, a Managing Partner at HealthScape Advisors. “Brad brings ... value-based care within the healthcare delivery system accelerates with the implementation of MACRA, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... Calif. , May 25, 2016  Zymo ... testing for their new reference materials that help ... from sample collection to analyses. The rapid growth ... demand for researchers to have standard methods to ... being generated. Biases inherently exist at every step ...
(Date:5/25/2016)... As illustrated by the Spring ... the numbers and momentum of cannabis in the US ... billions, more research and development push the sector forward. ... Legal Marijuana Markets Report  from from ArcView Market Research ... the increase in sector is attributed to adult use ...
(Date:5/25/2016)... -- MedDay, a biotechnology company focused on the ... entitled "High doses of biotin in progressive multiple sclerosis: extension ... Professor Ayman Tourbah , Principal Investigator of the Phase ... of Neurology (EAN) in Copenhagen, Denmark . ... place on Sunday, 29 May 2016 from 14:45 to 16:15 ...
Breaking Medicine Technology: